Salivary microbiome in peritoneal dialysis patients with and without sarcopenia: A pilot study
PLOS One · 2025
DOI: 10.1371/journal.pone.0330767 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Wararak Choovanichvong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Medicine and Periodontology, Faculty of Dentistry, Mahidol University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Saliva, Sarcopenia, Microbiota, Peritoneal Dialysis. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mahidol University.
Abstract (Originalsprache)
Purpose
To investigate salivary microbiota composition in end-stage kidney disease (ESKD) patients with sarcopenia (SESKD), ESKD patients without sarcopenia (NSESKD), and individuals without chronic kidney disease (control group). Materials and Methods Thirty-three participants were enrolled: 10 SESKD patients, 12 NSESKD patients, and 11 controls. Demographic data, oral examinations, and unstimulated saliva samples were collected. Salivary bacterial microbiomes were analyzed using high-throughput sequencing targeting the V3-V4 region of the bacterial 16S rRNA gene.
Results
The overall bacterial abundance and distribution were significantly higher in the SESKD and NSESKD groups compared to the control group ( p < 0.05), with no significant differences between the SESKD and NSESKD groups. ESKD, educational level, and muscle strength were significantly associated with variations in the salivary microbiome composition. Analysis of bacterial abundance revealed a shift in trends as the disease combined from control to NSESKD and SESKD group, respectively, across 7 genera: Actinobacillus , TM7x , Capnocytophaga , Neisseria , and Leptotrichia increased in abundance, while Actinomyces and Atopobium decreased. Linear discriminant analysis effect size (LEfSe) identified Leptotrichia as a potential biomarker for ESKD (both with and without sarcopenia).
Conclusion
ESKD condition impacted microbial composition, with minimal influence from sarcopenia. Specifically, Leptotrichia was notably higher in the ESKD group.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Oral Medicine and Periodontology, Faculty of Dentistry, Mahidol University, Bangkok, Thailand.
- Department of Oral Microbiology, Faculty of Dentistry, Mahidol University, Bangkok, Thailand.
- Division of Nephrology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
- Department of Epidemiology, Faculty of Public Health, Mahidol University, Bangkok, Thailand.
- Banphaeo-Charoenkrung Peritoneal Dialysis Center, Banphaeo Dialysis Group, Banphaeo Hospital, Bangkok, Thailand.
ORCID-Profile: Sirirak Supa-Amornkul, Sarinya Boongird, Sujiwan Seubbuk Sangkhamanee
Förderung
- Mahidol University
Zitieren
APA
Choovanichvong, W., Supa-Amornkul, S., Rungraungrayabkul, D., Boonyapratheeprat, N., Meenetkum, S., Boongird, S., Chuengsaman, P., Kitiyakara, C., & Sangkhamanee, S. S. (2025). Salivary microbiome in peritoneal dialysis patients with and without sarcopenia: A pilot study. PLOS One. https://doi.org/10.1371/journal.pone.0330767
Vancouver
Choovanichvong W, Supa-Amornkul S, Rungraungrayabkul D, Boonyapratheeprat N, Meenetkum S, Boongird S, et al. Salivary microbiome in peritoneal dialysis patients with and without sarcopenia: A pilot study. PLOS One. 2025. doi:10.1371/journal.pone.0330767
BibTeX
@article{Choovanichvong2025,
author = {Choovanichvong, Wararak and Supa-Amornkul, Sirirak and Rungraungrayabkul, Dulyapong and Boonyapratheeprat, Natcha and Meenetkum, Sasiwimon and Boongird, Sarinya and Chuengsaman, Piyatida and Kitiyakara, Chagriya and Sangkhamanee, Sujiwan Seubbuk},
title = {Salivary microbiome in peritoneal dialysis patients with and without sarcopenia: A pilot study},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0330767}
}
EUVIMED